Rapid Micro Biosystems (RPID) Change in Accured Expenses (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Change in Accured Expenses data on file, last reported at -$2.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 11.43% year-over-year to -$2.2 million; the trailing twelve-month figure through Mar 2026 stood at -$201000.0 (up 92.82% YoY), and the FY2025 full-year result was $28000.0, up 100.72% from the prior year.
• Change in Accured Expenses retreated to -$2.2 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $2.9 million in Q4 2023 to a low of -$3.9 million in Q1 2022.
• A 5-year average of -$436470.6 and a median of -$439000.0 in 2024 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses slumped 396.8% in 2022 and jumped 28860.0% in 2023, its largest moves.
• Tracing RPID's Change in Accured Expenses over 5 years: stood at $10000.0 in 2022, then jumped by 28860.0% to $2.9 million in 2023, then slumped by 115.16% to -$439000.0 in 2024, then jumped by 349.89% to $1.1 million in 2025, then slumped by 303.46% to -$2.2 million in 2026.
• Business Quant data shows RPID's Change in Accured Expenses at -$2.2 million in Q1 2026, $1.1 million in Q4 2025, and $599000.0 in Q3 2025.